Pfizer's Tokenized Stock, PFEX, Brings Blockchain Exposure to Pharmaceutical Giant
Pfizer's tokenized stock, PFEX, allows investors to gain exposure to the pharmaceutical company's shares through blockchain technology. The token is issued as both an ERC-20 token on Ethereum-compatible networks and a Solana SPL token, providing interoperability across two widely adopted blockchain standards. PFEX is backed by regulated custodial arrangements, ensuring that investors can access the tokenized equity while maintaining compliance with applicable financial regulations.
The xStocks platform, which tokenizes publicly traded equities and exchange-traded funds, is behind the development of PFEX. This platform seeks to bridge traditional capital markets and blockchain technology by issuing tokenized securities backed by real-world financial assets. PFEX is one of the tokenized equities available within the xStocks ecosystem, extending blockchain-based exposure to Pfizer Inc.
PFEX combines the accessibility of blockchain infrastructure with exposure to a globally recognized pharmaceutical company. The token provides price tracking, multi-chain availability, and fully collateralized structure, making it an attractive option for investors looking to access established public companies through digital asset ecosystems.